Is it safe to proceed with stem cell transplant in cancer patients treated for cryptococcal infection? A focus on recent IDSA cryptococcal guidelines

Lizbeth Cahuayme-Zuniga; Dimitrios P. Kontoyiannis

doi:10.1086/653010

Is it safe to proceed with stem cell transplant in cancer patients treated for cryptococcal infection? A focus on recent IDSA cryptococcal guidelines

Lizbeth Cahuayme-Zuniga, Dimitrios P. Kontoyiannis

Infectious Diseases, Infection Control, and Employee Health

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	1687-1689
Number of pages	3
Journal	Clinical Infectious Diseases
Volume	50
Issue number	12
DOIs	https://doi.org/10.1086/653010
State	Published - Jun 15 2010

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1086/653010

Cite this

@article{5db4a2f54d8d4faa8b4e2efa81380ebe,

title = "Is it safe to proceed with stem cell transplant in cancer patients treated for cryptococcal infection? A focus on recent IDSA cryptococcal guidelines",

author = "Lizbeth Cahuayme-Zuniga and Kontoyiannis, {Dimitrios P.}",

note = "Funding Information: member of the speakers{\textquoteright} bureau of and/or has received honoraria from Merck, Pfizer, Enzon, and Fujisawa/Astellas; he has received research support and/or grants from Merck, Enzon, and Fujisawa/ Astellas; and he has been a consultant and a mem-",

year = "2010",

month = jun,

day = "15",

doi = "10.1086/653010",

language = "English (US)",

volume = "50",

pages = "1687--1689",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "12",

}

TY - JOUR

T1 - Is it safe to proceed with stem cell transplant in cancer patients treated for cryptococcal infection? A focus on recent IDSA cryptococcal guidelines

AU - Cahuayme-Zuniga, Lizbeth

AU - Kontoyiannis, Dimitrios P.

N1 - Funding Information: member of the speakers’ bureau of and/or has received honoraria from Merck, Pfizer, Enzon, and Fujisawa/Astellas; he has received research support and/or grants from Merck, Enzon, and Fujisawa/ Astellas; and he has been a consultant and a mem-

PY - 2010/6/15

Y1 - 2010/6/15

UR - http://www.scopus.com/inward/record.url?scp=77952975983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952975983&partnerID=8YFLogxK

U2 - 10.1086/653010

DO - 10.1086/653010

M3 - Letter

C2 - 20482268

AN - SCOPUS:77952975983

SN - 1058-4838

VL - 50

SP - 1687

EP - 1689

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 12

ER -

Is it safe to proceed with stem cell transplant in cancer patients treated for cryptococcal infection? A focus on recent IDSA cryptococcal guidelines

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this